Heartbeam Inc SEC Filings

BEAT NASDAQ

Welcome to our dedicated page for Heartbeam SEC filings (Ticker: BEAT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Want to see how HeartBeam’s credit card–sized ECG device moves from FDA submission to commercial revenue? Our SEC filings hub puts every disclosure at your fingertips. From the latest HeartBeam insider trading Form 4 transactions to the quarterly earnings report 10-Q filing that details R&D spend on Vector ECG technology, each document is delivered seconds after it hits EDGAR.

AI-powered summaries break down complex medical terminology, so understanding HeartBeam SEC documents with AI feels as direct as reading a headline. Need real-time alerts? HeartBeam Form 4 insider transactions real-time feed flags executive stock transactions Form 4 the moment they’re posted. Looking for revenue guidance? The platform links straight to the HeartBeam earnings report filing analysis inside each 10-Q.

Different filings answer different investor questions: the HeartBeam annual report 10-K simplified shows long-term strategy and cash runway; an 8-K material events explained notice can reveal pivotal FDA feedback; the HeartBeam proxy statement executive compensation outlines how leadership is rewarded for device milestones. Our coverage spans everything—10-K, 10-Q, 8-K, S-1, Section 16 forms—paired with expert commentary that highlights clinical trial updates, patent developments, and mHealth market positioning.

Whether you’re monitoring HeartBeam insider trading Form 4 transactions before key 8-K releases or comparing trial expenses across quarters, Stock Titan’s AI turns dense disclosures into clear action points. Stop scrolling through hundreds of pages; start focusing on what moves the stock.

07/16/2025 02:15 PM

Filing

[8-K] Heartbeam, Inc. Reports Material Event

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

-- %

FAQ

What is the current stock price of Heartbeam (BEAT)?

The current stock price of Heartbeam (BEAT) is $1.27 as of July 18, 2025.

What is the market cap of Heartbeam (BEAT)?

The market cap of Heartbeam (BEAT) is approximately 42.9M.

What is HeartBeam Inc's primary business focus?

HeartBeam Inc specializes in high-resolution ambulatory ECG solutions and cloud-based diagnostic systems for remote cardiac monitoring. It combines portable hardware with advanced AI to enable accurate cardiac diagnostics outside of traditional healthcare settings.

How does the HeartBeam device compare to traditional ECG systems?

The HeartBeam device is designed to deliver a 12-lead equivalent ECG in a compact, credit card–sized format. Clinical studies have shown its diagnostic capabilities to be comparable to, and in some cases better than, conventional 12-lead ECG assessments conducted by cardiologists.

What role does AI and machine learning play in HeartBeam's technology?

AI and machine learning are integral to HeartBeam's diagnostic platform, continuously improving the system’s accuracy and predictive ability. These technologies analyze complex ECG data to refine diagnostic thresholds and support enhanced clinical decision-making.

What makes HeartBeam's technology clinically valuable?

The system’s clinical value lies in its ability to provide high-resolution, portable cardiac diagnostics validated by studies from Harvard Medical School. The integration of personalized diagnostic thresholds and novel ECG markers facilitates precise cardiac event location on 3D models.

How does HeartBeam ensure the accuracy of its diagnostics?

Accuracy is ensured through a combination of proprietary Vector ECG technology, rigorous clinical validation, and continual improvements driven by AI/ML algorithms. This multi-layered approach helps maintain high standards in diagnostic reliability.

What distinguishes HeartBeam from other telehealth and diagnostic companies?

HeartBeam distinguishes itself through its unique balance of portable hardware and sophisticated cloud-based analytics. Its innovative integration of advanced ECG technology, clinical validation, and AI-enhanced diagnostics sets it apart in the competitive digital health landscape.

In what environments can HeartBeam's technology be utilized?

The technology is suited for both clinical and out-of-hospital environments, enabling cardiac monitoring in ambulatory settings. Its portability and ease of use make it ideal for remote diagnostics and telehealth applications.

How does HeartBeam contribute to the advancement of digital cardiology?

By merging high-resolution diagnostic hardware with AI-driven data analysis, HeartBeam contributes to digital cardiology by providing more accessible, accurate, and efficient methods for diagnosing cardiac conditions. This innovation helps bridge the gap between traditional clinical assessments and modern telehealth practices.

Heartbeam Inc

NASDAQ:BEAT

BEAT Rankings

#7203 Ranked by Market Cap

N/A Ranked by Dividends

BEAT Stock Data

Market Cap 42.94M

Float 25.65M

Insiders Ownership 23.17%

Institutions Ownership 7.89%

Short Percent 0.68%

Industry Health Information Services

Sector Surgical & Medical Instruments & Apparatus

Website Link

Country United States

City SANTA CLARA